P806-0710 Screening compound: 1-acetyl-N-{1-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidin-3-yl}piperidine-4-carboxamide

P806-0710 Screening compound: 1-acetyl-N-{1-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidin-3-yl}piperidine-4-carboxamide
P806-0710 Screening compound: 1-acetyl-N-{1-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidin-3-yl}piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P806-0710
1-acetyl-N-{1-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidin-3-yl}piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P806-0710

Molecular Formula

C22H28ClN5O2 (C22 H28 ClN5 O2)

Compound Name

1-acetyl-N-{1-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidin-3-yl}piperidine-4-carboxamide

IUPAC name

1-acetyl-N-{1-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidin-3-yl}piperidine-4-carboxamide

SMILES

CC(N(CC1)CCC1C(NC(CCC1)CN1c1cc(-c(cc2)ccc2Cl)n[nH]1)=O)=O

InChI

InChI=1S/C22H28ClN5O2/c1-15(29)27-11-8-17(9-12-27)22(30)24-19-3-2-10-28(14-19)21-13-20(25-26-21)16-4-6-18(23)7-5-16/h4-7,13,17,19H,2-3,8-12,14H2,1H3,(H,24,30)(H,25,26)/t19-/m0/s1

InChI Key

BJTRHMHNQNNOJH-IBGZPJMESA-N

MDL Number (MFCD)

MFCD28998946

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.95

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.753

Distribution Coefficient, logD

2.753

Water Solubility, LogSw

-3.62

Polar Surface Area

66.912

Acid Dissociation Constant (pKa)

14.43

Base Dissociation Constant (pKb)

6.89

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

P806-0710 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
  • Cancer
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with P806-0710 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P806-0710?
Check Price and Availability of P806-0710, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P806-0710 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P806-0710
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P806-0710
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P806-0710 available by request